FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.Associated PressWASHINGTON (AP) — When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of voices: doctors and pharmacists with deep financial ties to the burgeoning industry of unproven chemicals. States Sue Trump Administration Over Medicaid Work RequirementsNew York TimesThe lawsuit argues that new federal rules went beyond what Congress enacted and broke from guidance that the federal government previewed to states.